CC
Callan Capital Portfolio holdings
AUM
$1.35B
This Quarter Return
+10.18%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$810M
AUM Growth
+$810M
(+32%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
16.45%
Top 10 Holdings %
Top 10 Hldgs %
49.65%
Holding
195
New
66
Increased
84
Reduced
25
Closed
9
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 3.22% |
| 2 | Healthcare | 1.73% |
| 3 | Financials | 1.6% |
| 4 | Real Estate | 0.78% |
| 5 | Communication Services | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares US Equity Factor ETF
LRGF
$2.81B
| $280K | 0.03% |
7,174
-23,228
| -76% | -$906K |
|
152
Halozyme
HALO
$8.58B
| $271K | 0.03% |
+4,770
| New | +$271K |
|
153
Citigroup
C
$174B
| $270K | 0.03% |
+5,971
| New | +$270K |
|
154
Visa
V
$679B
| $268K | 0.03% |
1,292
-151
| -10% | -$31.4K |
|
155
Walt Disney
DIS
$213B
| $267K | 0.03% |
3,068
-1,271
| -29% | -$110K |
|
156
Vanguard Small-Cap ETF
VB
$66.1B
| $266K | 0.03% |
1,451
+9
| +0.6% | +$1.65K |
|
157
Philip Morris
PM
$261B
| $266K | 0.03% |
+2,626
| New | +$266K |
|
158
Bristol-Myers Squibb
BMY
$96.5B
| $257K | 0.03% |
+3,575
| New | +$257K |
|
159
Analog Devices
ADI
$122B
| $249K | 0.03% |
+1,516
| New | +$249K |
|
160
Accenture
ACN
$160B
| $244K | 0.03% |
916
| – | – |
|
161
General Motors
GM
$55.7B
| $243K | 0.03% |
+7,216
| New | +$243K |
|
162
PayPal
PYPL
$66.2B
| $242K | 0.03% |
3,399
+576
| +20% | +$41K |
|
163
Principal Investment Grade Corporate Active ETF
IG
$120M
| $240K | 0.03% |
+11,762
| New | +$240K |
|
164
Invesco S&P 500 Equal Weight ETF
RSP
$73.6B
| $230K | 0.03% |
+1,630
| New | +$230K |
|
165
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$553M
| $228K | 0.03% |
3,778
-130
| -3% | -$7.84K |
|
166
Lowe's Companies
LOW
$145B
| $228K | 0.03% |
1,143
| – | – |
|
167
Exxon Mobil
XOM
$489B
| $223K | 0.03% |
+2,019
| New | +$223K |
|
168
Boeing
BA
$179B
| $222K | 0.03% |
+1,164
| New | +$222K |
|
169
IQVIA
IQV
$31.2B
| $220K | 0.03% |
+1,074
| New | +$220K |
|
170
SPDR S&P Biotech ETF
XBI
$5.25B
| $219K | 0.03% |
+2,635
| New | +$219K |
|
171
Vanguard Large-Cap ETF
VV
$44.1B
| $214K | 0.03% |
+1,231
| New | +$214K |
|
172
Deere & Co
DE
$129B
| $212K | 0.03% |
+494
| New | +$212K |
|
173
Linde
LIN
$222B
| $209K | 0.03% |
+641
| New | +$209K |
|
|
USBC
174
USBC, Inc.
USBC
$379M
| $208K | 0.03% |
+130,000
| New | +$208K |
|
175
AstraZeneca
AZN
$249B
| $207K | 0.03% |
+3,047
| New | +$207K |
|